fatigue
[대역어] 피로
[용어속성] Symptom
[용어속성] Symptom
Disentangling post-vaccination symptoms from early COVID-19
Research paper
[키워드] 1:1
Asymptomatic
AUC, area under the curve
bMEM, Bayesian mixed-effect model
BMI, Body mass index
BNT162b2
ChAdOx1 nCoV-19
chronic
CI, Confidence interval
clinical information
Community
Comorbidities
conducted
cough
Council
COVID
COVID-19
COVID-19 detection
COVID-19, Coronavirus disease 2019
criteria
Critical
CSS
CSS, COVID Symptoms Study
demographic
Department
DI, Data invalid
Early detection
Engineering
fatigue
Fever
finding
foundation
funding
headache
heart
identifying
individual
infection control
injection
IQR, inter quartile range
KCL, King's College London
LFAT, Lateral flow antigen test
Local
LR, Logistic Regression
Medical Research Council
Mobile technology
MOST
myalgia
NHS UK, National Health Service of the United Kingdom
O-AZ, Oxford-AstraZeneca adenovirus-vectored vaccine
overlap
Oxford-AstraZeneca adenovirus-vectored vaccine
participant
Participants
PB, Pfizer-BoiNTech mRNA vaccine
Pfizer-BioNTech mRNA vaccine
positive
post-vaccination symptom
presenting
Prevent
profile
prospective observational study
public health
reduce
reported symptom
RF, Random forest
ROC, Receiver operating curve
rtPCR, Reverse transcription polymerase chain reaction
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 test
SARS-CoV-2, Severe acute respiratory syndrome-related coronavirus-2
Science
Self-reported symptoms
sensitivity
Seven
severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2)
severe acute respiratory syndrome‐related coronavirus 2 (SARS-CoV-2)
Side-effect
Side-effects
Spread
Symptom
Symptoms
systemic symptom
tested
UK, United Kingdom of Great Britain and Nothern Ireland
vaccination
were recorded
with COVID-19
[DOI] 10.1016/j.eclinm.2021.101212 PMC 바로가기 [Article Type] Research paper
[DOI] 10.1016/j.eclinm.2021.101212 PMC 바로가기 [Article Type] Research paper
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
HIV-1에 감염된 사람들에서 BNT162b2 mRNA COVID-19 백신의 면역원성과 안전성
Article
[키워드] 95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
Adverse
adverse event
adverse events
AIDS
anti-RBD
Antiretroviral therapy
appear
BNT162b2
BNT162b2 mRNA
BNT162b2 mRNA vaccine
CD4
CD4 cell
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19 vaccine
disease
enrolled
event
events
fatigue
geometric
geometric mean
HCWs
headache
health-care
HIV-1
Human
Human immunodeficiency virus
IgG
immune
immunodeficiency
immunodeficiency virus
immunogenic
immunogenicity
injection
injection site
interquartile range
median
mRNA vaccine
neutralized
Neutralizing antibodies
neutralizing antibody
open
Pain
Patient
Pfizer-BioNTech
PLWH
positive
pseudo-virus
RBD
Receptor binding domain
reported
respiratory
Safe
SARS-CoV-2
second dose
sera
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
suppressed
T-cell
vaccination
Vaccine
Viral
Viral load
were measured
[DOI] 10.1016/j.cmi.2021.07.031 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cmi.2021.07.031 PMC 바로가기 [Article Type] Article
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
SARS-CoV-2 백신 후 자가면역 간염: 새로운 발병 또는 재발?
Case Reports
[키워드] abnormal immune response
Activation
acute respiratory syndrome
antibody
antinuclear antibody
Autoimmune disease
Autoimmune diseases
Autoimmune hepatitis
Autoimmune reaction
Bilirubin
BNT162b2 mRNA vaccine
bystander
clinician
coronavirus
COVID-19
COVID-19 vaccine
develop
diagnosed
disease
elevated
eyes
fatigue
Hepatitis
histopathological finding
Immunoglobulin
Infection
initiated
Intensive
jaundice
Laboratory test
liver
liver enzyme
loss of appetite
malaise
molecular
mRNA vaccine
multifactorial
nausea
Patient
Pfizer/BioNTech
Physical examination
positive
potential mechanism
presenting
reported
SARS-CoV-2
SARS-CoV-2 mRNA vaccine
SARS-CoV-2 vaccines
scoring system
susceptible individuals
Symptoms
therapy
vaccination
[DOI] 10.1016/j.jaut.2021.102745 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.jaut.2021.102745 PMC 바로가기 [Article Type] Case Reports
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19
Observational Study
[키워드] Admission
age
baseline
COVID-19
COVID-19 hospitalization
demonstrated
determine
discharge
discharged
domain
Dyspnea
fatigue
female
functional
Health
Health status
health system
hospital discharge
Hospitalization
Hospitalized
IMPROVE
Infection
interquartile range
IQR
long-COVID
majority
median
mental health
Observational cohort study
outcomes
oxygen
Oxygen requirement
participant
Patient
Patient-reported outcomes
physical
post-discharge outcomes.
Prospective
remained
reported
required
returned
Seven
severe COVID-19
Shortness of breath
Standard deviation
supplemental oxygen
Symptom
Symptoms
Treatment
were assessed
[DOI] 10.1007/s11606-021-07032-9 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s11606-021-07032-9 PMC 바로가기 [Article Type] Observational Study
Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
2019 코로나바이러스 감염증(COVID-19) 환자를 위한 렘데시비르의 80세 이상 환자 안전성
Article
[키워드] administration
adverse event
adverse events
age
Clinical practice
comparable
coronavirus disease
Coronavirus disease 2019
COVID-19
defined
evaluate
evaluated
Exacerbation
fatigue
high risk
Hospitalization
incidence
liver dysfunction
medication
no significant difference
no significant differences
occurred
Older
older patient
older patients
Patient
patients
patients older
patients with COVID-19
Remdesivir
renal dysfunction
required
Safety
suggested
treated
Treatment
with COVID-19
Year
younger patient
younger patients
[DOI] 10.1007/s40266-021-00908-9 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s40266-021-00908-9 PMC 바로가기 [Article Type] Article
[Bilateral central serous chorioretinopathy post-COVID-19]
[양측 중심 장액 맥락망막병증 post-COVID-19]
Case Reports
[키워드] administration
anterior segment
Antibiotics
blurred vision
both eyes
Central serous chorioretinopathy
characterized
Choriorétinopathie séreuse centrale
coronavirus disease
Corticoïdes
Corticosteroid
Corticosteroids
cough
Course
COVID-19
COVID-19 infection
Décollements séreux rétiniens
detect
disease
English
eyes
fatigue
Fever
Fluorescein
fluorescein angiography
French
Fundus
Fundus examination
heparin
Hospital stay
Infection
infection with COVID-19
Ink-blot leakage
intravenously
manifestation
Manifestations
MOIs
nous
occur
ocular
Optical coherence tomography
oxygen
PCR positive
Point
Points de fuite
positive
Post-infection
Regression
reported
Serous
Serous retinal detachments.
Shortness of breath
the patient
virus
visual acuity
visual loss
vitreous
with COVID-19
[DOI] 10.1016/j.jfo.2021.10.001 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.jfo.2021.10.001 PMC 바로가기 [Article Type] Case Reports
Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation
Clinical Trial
[키워드] activities
allogeneic HSCT
Anxiety
association
baseline
Cancer
cancer diagnosis
Care
Cohort
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 pandemic
cross-sectional analysis
demographics
Depression
disease risk
disorder
distress
early recovery
enrolled
Enrollment
exacerbating
Factors
fatigue
hematopoietic
HSCT
impairment
implication
Isolation
life
Linear regression model
negative and positive
no difference
outcomes
pandemic
participant
Patient
Patient-reported outcomes
positive
Posttraumatic Stress
PTSD
Quality
Quality of life
recipient
regression models
reported
STEM
Stem cell transplantation
Stress
supportive care
Symptom
symptoms of depression
transplantation
Trial
[DOI] 10.1016/j.jtct.2021.09.001 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/j.jtct.2021.09.001 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 in Africa: rethinking the tools to manage future pandemics
Articles
[키워드] acute respiratory syndrome
affected
Americas
Asia
characterized
Corona virus
COVID-19
disease
dry cough
early stages
Ebola
effective
Epidemic
Epidemics
Europe
expected
fatigue
Fever
First wave
Future Pandemics
headache
Health leadership
incurable
infections
lowest
Mortality
overcome
pandemic
Pandemics
Preventative Health
public health
rate of infection
rates of infection
recommendation
recorded
SARS-CoV-2
Science Leadership in Africa
Transmission
Vaccine
virus
WHO
World Health Organization
[DOI] 10.4314/ahs.v21i4.3 PMC 바로가기 [Article Type] Articles
[DOI] 10.4314/ahs.v21i4.3 PMC 바로가기 [Article Type] Articles